Fierce Pharma August 12, 2022
Teresa Carey

Sunday, the U.S. Senate passed the landmark drug pricing bill. While the pharmaceutical industry favors the bill’s Medicare out-of-pocket cap for patients, the industry has also put up a major fight against Medicare pricing negotiations, in fact deeming them “price controls.” The bill’s passage marked a loss for the industry, but analysts aren’t sure how much the legislation will actually cut...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Congress / White House, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech, Regulations, Trends
Johns Hopkins scientists depict molecular pathway to track replication in cancer cells
STAT+: After gene therapy, two congenitally deaf children hear for the first time
Pharma has over $500B in capital for deals
Could this genetic variant cause some Alzheimer's cases? What a new study suggests.
Opinion: It shouldn’t be easy to buy synthetic DNA fragments to recreate the 1918 flu virus

Share This Article